{"transactions":[{"id":766025,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":true,"shares":4471,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents receipt of shares in the distribution in kind described in footnote (3)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Securities are held by Samsara BioCapital Partners. Dr. Akkaraju has voting and investment power over the shares held by Samsara BioCapital Partners and, accordingly, may be deemed to beneficially own the shares held by Samsara BioCapital Partners. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":19408,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766024,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":true,"shares":14937,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital GP, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents receipt of shares in the distribution in kind described in footnote (3)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Securities are held by Samsara LLC. Dr. Akkaraju has voting and investment power over the shares held by Samsara LLC and, accordingly, may be deemed to beneficially own the shares held by Samsara LLC. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":14937,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766023,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":false,"shares":66906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata, in-kind distribution, without additional consideration, and not a purchase or sale of securities, by Samsara LP in respect of redeemed interests in Samsara LP.  Of the shares distributed by Samsara LP, (i) 47,498 were distributed to redeeming limited partners, (ii) 14,937 shares were distributed to Samsara BioCapital GP, LLC (\"Samsara LLC\"), the general partner of Samsara LP, in respect of redeemed interests of non-managing members of Samsara LLC that were retained by Samsara LLC, and (iii) 4,471 shares were distributed to Samsara BioCapital Partners, L.P. (\"Samsara BioCapital Partners\"), in respect of the redeemed interest of a limited partner of Samsara LP that has been acquired by Samsara BioCapital Partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares held by Samsara LP reflects the disposition of 244,300\nshares, to Samsara Opportunity Fund as described in footnote (1), in which each of Samsara LLC and Dr. Akkaraju had no pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are held by Samsara LP. Samsara LLC is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":10657028,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766022,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":244300,"price":4.83,"value":1179969.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the purchase of shares from Samsara BioCapital, L.P. (\"Samsara LP\") in a privately negotiated transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":2224147,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":901136,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T01:15:32.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":479847,"price":10.42,"value":5000005.74,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the purchase of shares from Samsara BioCapital, L.P. (\"Samsara LP\") in a privately negotiated transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the number of shares held as of the date of this filing, including the shares purchased by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") on December 22, 2025, as reported in the reporting persons' Form 4 filed with the SEC on December 22, 2025 (the \"Prior Report\").  The Prior Report is deemed amended hereby."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1979847,"source":{"system":"sec-edgar","filing":"0001231919-26-000166","document":"form4-02182026_010226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000166/form4-02182026_010226.xml","form_type":"4"}},{"id":1203237,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T01:05:47.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":600000,"price":13.5,"value":8100000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are directly held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein."}],"balance_after":5674916,"source":{"system":"sec-edgar","filing":"0001415889-25-008275","document":"form4-03182025_010343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699737/000141588925008275/form4-03182025_010343.xml","form_type":"4"}},{"id":1249214,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-24T23:59:33.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":32900,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001933414-25-000018","document":"wk-form4_1740441567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341425000018/wk-form4_1740441567.xml","form_type":"4"}},{"id":1340102,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre- Funded Warrants (Right to Buy)","published_at":"2024-12-06T21:15:18.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":58885,"ownership":{"direct":false,"nature":"Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership in these securities except to the extent of its pecuniary interest therein. Dr. Akkaraju is a director of the Issuer and files separate Section 16 reports."}],"balance_after":892578,"derivative":{"exercise_price":0.01,"underlying":"Class A Common Stock","underlying_shares":58885},"source":{"system":"sec-edgar","filing":"0001415889-24-028465","document":"form4-12062024_041204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000141588924028465/form4-12062024_041204.xml","form_type":"4"}},{"id":1340101,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-06T21:15:18.000Z","date":"2024-03-05","kind":"other","planned":false,"acquired":false,"shares":58836,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership in these securities except to the extent of its pecuniary interest therein. Dr. Akkaraju is a director of the Issuer and files separate Section 16 reports."}],"balance_after":206784,"source":{"system":"sec-edgar","filing":"0001415889-24-028465","document":"form4-12062024_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641489/000141588924028465/form4-12062024_041204.xml","form_type":"4"}},{"id":1349176,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":27.5,"value":55000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $27.48 to $27.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1717127,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349175,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":15219,"price":26.73,"value":406803.87,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.46 to $26.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1715127,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349174,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":10803,"price":26.01,"value":280986.03,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.47 to $26.44 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1699908,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349173,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":20748,"price":24.91,"value":516832.68,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $24.25 to $25.23 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1689105,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1494902,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T01:45:28.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":294000,"price":17,"value":4998000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":4415689,"source":{"system":"sec-edgar","filing":"0001415889-24-015250","document":"form4-06042024_010623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924015250/form4-06042024_010623.xml","form_type":"4"}},{"id":1503409,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2024-05-23T20:21:46.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting."}],"balance_after":22000,"derivative":{"exercise_price":12.52,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001933414-24-000021","document":"wk-form4_1716495693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341424000021/wk-form4_1716495693.xml","form_type":"4"}},{"id":1642572,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T02:06:11.000Z","date":"2024-02-12","kind":"purchase","planned":false,"acquired":true,"shares":555555,"price":13.5,"value":7499992.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara BioCapital, L.P. (\"Samsara LP\") and may be deemed to beneficially own the shares held by Samsara LP.  Samsara LLC disclaims beneficial ownership in these shares except to the extent of its pecuniary interest therein."}],"balance_after":5074916,"source":{"system":"sec-edgar","filing":"0001415889-24-003859","document":"form4-02152024_020259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699737/000141588924003859/form4-02152024_020259.xml","form_type":"4"}},{"id":1738813,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":1833623,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1833623},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738812,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":884400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":884400},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738811,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":663300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":663300},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738810,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":666666,"price":15,"value":9999990.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":4121689,"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738809,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":true,"shares":3381323,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":3455023,"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1758168,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-18T21:44:33.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":2189781,"price":6.85,"value":14999999.85,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Samsara BioCapital LP (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Samsara LLC disclaims beneficial ownership in these shares except to the extent of its respective pecuniary interest therein. Dr. Akkaraju is a director of Issuer and files separate Section 16 reports."}],"balance_after":6788609,"source":{"system":"sec-edgar","filing":"0001209191-23-053111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000120919123053111/doc4.xml","form_type":"4"}},{"id":2010612,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2023-02-16T21:54:22.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":1446357,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara BioCapital, L.P. (\"Samsara LP\") and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1446357},"source":{"system":"sec-edgar","filing":"0001628280-23-003923","document":"wf-form4_167658444611991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000162828023003923/wf-form4_167658444611991.xml","form_type":"4"}},{"id":2010611,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-02-16T21:54:22.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":2135504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara BioCapital, L.P. (\"Samsara LP\") and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2135504},"source":{"system":"sec-edgar","filing":"0001628280-23-003923","document":"wf-form4_167658444611991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000162828023003923/wf-form4_167658444611991.xml","form_type":"4"}},{"id":2010610,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T21:54:22.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":937500,"price":16,"value":15000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara BioCapital, L.P. (\"Samsara LP\") and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":4519361,"source":{"system":"sec-edgar","filing":"0001628280-23-003923","document":"wf-form4_167658444611991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000162828023003923/wf-form4_167658444611991.xml","form_type":"4"}},{"id":2010609,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T21:54:22.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":3581861,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Samsara BioCapital, L.P. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara BioCapital, L.P. (\"Samsara LP\") and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":3581861,"source":{"system":"sec-edgar","filing":"0001628280-23-003923","document":"wf-form4_167658444611991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000162828023003923/wf-form4_167658444611991.xml","form_type":"4"}},{"id":2019567,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-02-14T02:02:23.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 monthly installments beginning on March 9, 2023."}],"balance_after":44000,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-23-003427","document":"wf-form4_167634012632329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000162828023003427/wf-form4_167634012632329.xml","form_type":"4"}},{"id":2297826,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T23:40:47.000Z","date":"2022-04-12","kind":"purchase","acquired":true,"shares":350000,"price":4.08,"value":1428000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":8459314,"source":{"system":"sec-edgar","filing":"0001209191-22-024364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/doc4.xml","form_type":"4"}},{"id":2297825,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-13T23:40:47.000Z","date":"2022-04-11","kind":"purchase","acquired":true,"shares":74464,"price":4.07,"value":303068.48,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":8109314,"source":{"system":"sec-edgar","filing":"0001209191-22-024364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122024364/doc4.xml","form_type":"4"}},{"id":2426843,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T19:30:20.000Z","date":"2022-01-24","kind":"purchase","acquired":true,"shares":23000,"price":8.7,"value":200100.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.67 to $8.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":8034850,"source":{"system":"sec-edgar","filing":"0001209191-22-004735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122004735/doc4.xml","form_type":"4"}},{"id":2426842,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T19:30:20.000Z","date":"2022-01-21","kind":"purchase","acquired":true,"shares":100000,"price":8.99,"value":899000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.90 to $9.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":8011850,"source":{"system":"sec-edgar","filing":"0001209191-22-004735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122004735/doc4.xml","form_type":"4"}},{"id":2428818,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-21T18:48:27.000Z","date":"2022-01-20","kind":"purchase","acquired":true,"shares":43105,"price":8.92,"value":384496.6,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.83 to $8.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7911850,"source":{"system":"sec-edgar","filing":"0001209191-22-004346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122004346/doc4.xml","form_type":"4"}},{"id":2428817,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-21T18:48:27.000Z","date":"2022-01-19","kind":"purchase","acquired":true,"shares":54565,"price":9.24,"value":504180.6,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.64 to $9.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7868745,"source":{"system":"sec-edgar","filing":"0001209191-22-004346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919122004346/doc4.xml","form_type":"4"}},{"id":2464089,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T18:46:14.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":22329,"price":10.19,"value":227532.51,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.16 to $10.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7814180,"source":{"system":"sec-edgar","filing":"0001209191-21-070500","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121070500/doc4.xml","form_type":"4"}},{"id":2495603,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T18:31:09.000Z","date":"2021-11-22","kind":"purchase","acquired":true,"shares":201685,"price":10.15,"value":2047102.75,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.15 to $10.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7791851,"source":{"system":"sec-edgar","filing":"0001209191-21-066742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121066742/doc4.xml","form_type":"4"}},{"id":2541753,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T22:06:58.000Z","date":"2021-10-15","kind":"purchase","acquired":true,"shares":2300,"price":12.49,"value":28727.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7590166,"source":{"system":"sec-edgar","filing":"0001209191-21-060627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060627/doc4.xml","form_type":"4"}},{"id":2541752,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T22:06:58.000Z","date":"2021-10-14","kind":"purchase","acquired":true,"shares":3100,"price":12.5,"value":38750.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7587866,"source":{"system":"sec-edgar","filing":"0001209191-21-060627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060627/doc4.xml","form_type":"4"}},{"id":2541751,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T22:06:58.000Z","date":"2021-10-13","kind":"purchase","acquired":true,"shares":45400,"price":13.22,"value":600188.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.11 to $13.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7584766,"source":{"system":"sec-edgar","filing":"0001209191-21-060627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060627/doc4.xml","form_type":"4"}},{"id":2545566,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T21:09:14.000Z","date":"2021-10-08","kind":"purchase","acquired":true,"shares":75000,"price":13.12,"value":984000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7539366,"source":{"system":"sec-edgar","filing":"0001209191-21-060060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060060/doc4.xml","form_type":"4"}},{"id":2545565,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T21:09:14.000Z","date":"2021-10-07","kind":"purchase","acquired":true,"shares":9021,"price":14.94,"value":134773.74,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.49 to $15.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7464366,"source":{"system":"sec-edgar","filing":"0001209191-21-060060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060060/doc4.xml","form_type":"4"}},{"id":2545564,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":2,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T21:09:14.000Z","date":"2021-10-06","kind":"purchase","acquired":true,"shares":61475,"price":13.83,"value":850199.25,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.40 to $14.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7455345,"source":{"system":"sec-edgar","filing":"0001209191-21-060060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121060060/doc4.xml","form_type":"4"}},{"id":2647972,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":55336,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by 436, L.P. (\"436 LP\"). 436, LLC (\"436 LLC\") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22753},"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647971,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":1802372,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":741107},"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647970,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":15000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6167763},"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647969,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":15000,"price":17,"value":255000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by 436, L.P. (\"436 LP\"). 436, LLC (\"436 LLC\") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":37753,"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647968,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":485000,"price":17,"value":8245000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":7393870,"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647967,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":22753,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by 436, L.P. (\"436 LP\"). 436, LLC (\"436 LLC\") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":22753,"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647966,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":741107,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":6908870,"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}},{"id":2647965,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":1,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137691,"kind":"organization","name":"436, L.P.","position":2,"cik":"0001844560","reported_name":"436, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:39:35.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":6167763,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the redeemable convertible preferred stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") for no additional consideration, on a one-for-2.432 basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein."}],"balance_after":6167763,"source":{"system":"sec-edgar","filing":"0001209191-21-044507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120919121044507/doc4.xml","form_type":"4"}}]}